| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,803,000 | 10,162,000 | 9,396,000 | 10,767,000 | | Cost of Revenue | 6,262,000 | 6,497,000 | 6,131,000 | 7,373,000 | | | Gross Profit | 3,541,000 | 3,665,000 | 3,265,000 | 3,394,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,133,000 | 2,140,000 | 1,991,000 | 2,370,000 | | Non Recurring | (17,000) | (9,000) |
-
| 717,000 | | Others | 6,000 | 3,000 | 6,000 | 5,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,419,000 | 1,531,000 | 1,268,000 | 302,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 32,000 | | Earnings Before Interest And Taxes | 1,419,000 | 1,531,000 | 1,268,000 | 334,000 | | Interest Expense | 323,000 | 312,000 | 280,000 | 338,000 | | Income Before Tax | 1,096,000 | 1,219,000 | 988,000 | (4,000) | | Income Tax Expense | 270,000 | 390,000 | 326,000 | (90,000) | | Minority Interest | (6,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 826,000 | 829,000 | 662,000 | 86,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 77,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 820,000 | 829,000 | 662,000 | 163,000 | | Preferred Stock And Other Adjustments | 4,000 | (2,000) | (2,000) |
-
| | | Net Income Applicable To Common Shares | $824,000 | $827,000 | $660,000 | $163,000 |
|
1.48% Nasdaq 
Income Statement
